Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lindsey J. Loera"'
Autor:
Amber R. Tran, BS, Saumyaa A. Patel, BS, Lindsey J. Loera, PharmD, Tawny Smith, PharmD, BCPP, Samantha Catanzano, PharmD, BCPP
Publikováno v:
Mental Health Clinician, Vol 14, Iss 1, Pp 73-78 (2024)
Introduction Mental health–related stigma is a barrier to treatment and recovery for serious mental illnesses (SMIs). Educational training programs demonstrate positive changes in health professional students’ attitudes and stigma toward SMI; how
Externí odkaz:
https://doaj.org/article/56360b21327441ccb5601feea9cd3a5d
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:521-527
Autor:
Jessica Duncan Cance, Amanda Bingaman, Heather Kane, Sara Hairgrove, Sorina B. Torrez, Austin Buck, Claire M. Zagorski, Lindsey J. Loera, Lucas G. Hill
Publikováno v:
Journal of the American Pharmacists Association. 63:317-323
The prevalence of deaths involving synthetic opioids has historically been lower in Texas than most U.S. states but more than quadrupled from January 2020 to January 2022. This paper explores the emergence of fentanyl in a drug supply where black tar
Autor:
Kelley M. White, Lucas G. Hill, Joshua C. Perez, Sorina B. Torrez, Claire M. Zagorski, Lindsey J. Loera
Publikováno v:
Substance Abuse. 43:749-755
Publikováno v:
Journal of the American Pharmacists Association : JAPhA.
People who inject drugs (PWID) are subject to injection-related harm, including skin and soft tissue infections. Syringe services programs (SSPs) provide sterile syringes, disposal of used syringes, and other supportive services. Given their contact
Autor:
Lucas G. Hill, Mandy L Renfro, Claire M. Zagorski, Kirk E. Evoy, Joshua C. Perez, Shaun M. Jones, Lindsey J. Loera, Kelly R. Reveles, Sorina B. Torrez
Publikováno v:
Addiction
BACKGROUND AND AIMS Patients with opioid use disorder (OUD) must be able to obtain prescribed buprenorphine/naloxone films (BUP/NX) and naloxone nasal spray (NNS) from a pharmacy promptly to reduce risk for a recurrence of use and subsequent morbidit
Publikováno v:
The Mental Health Clinician
Introduction Maintaining abstinence through the opioid withdrawal period is a substantial barrier to treatment for patients with opioid use disorder. The alpha-2 agonist lofexidine has demonstrated efficacy and safety in clinical trials, but pragmati
Publikováno v:
Am J Pharm Educ
Objective. To assess the impact of a pilot advanced pharmacy practice experience (APPE) on fourth-year (P4) Doctor of Pharmacy (PharmD) students’ knowledge and confidence related to substance use disorder, harm reduction, and co-occurring psychiatr
Publikováno v:
The International Journal on Drug Policy